Retrovirus-induced target cell activation in the early phases of infection: The mouse mammary tumor virus model

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7295-7299

  Ardavin, Carlos ^a   Luthi, Frédéric ^b   Andersson, Mikael ^c   Scarpellino, Leo ^c   Martin, Pilar ^a   Diggelmann, Heidi ^b   Acha Orbea, Hans ^c,d  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; IMMUNOREACTIVITY; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS INFECTION; T LYMPHOCYTE ACTIVATION; VIRUS CELL INTERACTION;

EID: 0030846167     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7295-7299.1997     Document Type: Article

References (32)

1. Acha-Orbea, H., and H. R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13:459-486.
2. β14 positive T cells in mammary tumor virus transgenic mice. Nature 350:207-211.
3. Acha-Orbea, H., R. M. Zinkernagel, and H. Hengartner. 1985. Cytotoxic T cell clone-specific monoclonal antibodies used to select clonotypic antigenspecific cytotoxic T cells. Eur. J. Immunol. 15:31-36.
4. Bachmann, M. F., H. Hengartner, and R. M. Zinkernagel. 1995. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction? Eur. J. Immunol. 25:3445-3451.
5. Bentvelzen, P., and J. Hilgers. 1980. Murine mammary tumor virus, p. 311-355. In G. Klein (ed.), Viral oncology. Raven Press, New York, N.Y.
6. Bukrinsky, M. I., S. Haggerty, M. P. Dempsey, N. Sharova, A. Adzhubel, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman, and M. Stevenson. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of nondividing cells. Nature 365:666-669.
7. Choi, Y., J. W. Kappler, and P. Marrack. 1991. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumor virus. Nature 350:203-207.
8. Del Prete, G., M. De Carli, M. M. D'Elios, I. M. Fleckenstein, H. Fickenscher, B. Fleckenstein, F. Almerigogna, and S. Romagnani. 1994. Polyclonal B cell activation induced by herpesvirus saimiri-transformed human CD4+ T cell clones. Role for membrane TNF-alpha/TNF-alpha receptors and CD2/ CD58 interactions. J. Immunol. 153:4872-4879.
9. 8a.Finke, D., L. Montezavi, S. Izui, and H. Acha-Orbea. Unpublished data.
10. Gao, W. Y., A. Cara, R. C. Gallo, and F. Lori. 1993. Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit HIV type 1 replication. Proc. Natl. Acad. Sci. USA 90:8925-8928.
11. Golovkina, T. V., A. Chervonsky, J. P. Dudley, and S. R. Ross. 1992. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69:637-645.
12. Held, W., A. N. Shakhov, S. Izui, G. A. Waanders, L. Scarpellino, H. R. MacDonald, and H. Acha-Orbea. 1993. Superantigen-reactive CD4+ T cells arc required to stimulate B cells after infection with mouse mammary tumor virus. J. Exp. Med. 177:359-366.
13. Held, W., A. N. Shakhov, G. Waanders, L. Scarpellino, R. Luethy, J. P. Krachenbuhl, H. R. MacDonald, and H. Acha-Orbea. 1992. An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7). J. Exp. Med. 175:1623-1633.
14. Held, W., G. A. Waanders, H. Acha-Orbea, and H. R. MacDonald. 1994. Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function. J. Exp. Med. 180:2347-2351.
15. Held, W., G. A. Waanders, H. R. MacDonald, and H. Acha-Orbea. 1994. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus. Int. Immunol. 6:1403-1407.
16. Held, W., G. A. Waanders, A. N. Shakhov, L. Scarpellino, H. Acha-Orbea, and H. R. MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74:529-540.
17. Krummenacher, C., H. Diggelmann, and H. Acha-Orbea. 1996. In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen. J. Virol. 70:3026-3031.
18. + T cells. J. Exp. Med. 170:135-143.
19. Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, an C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271-279.
20. Nusse, R., and H. E. Varmus. 1982. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31:99-109.
21. Nusse, R., and H. E. Varmus. 1992. Wnt genes. Cell 69:1073-1087.
22. β6 of the murine T cell receptor. Proc. Natl. Acad. Sci. USA 85:7695-7698.
23. Price, P., S. D. Olver, A. E. Gibbons, and G. R. Shellam. 1993. B-cell activation following murine cytomegalovirus infection: implications for autoimmunity. Immunology 78:14-21.
24. Roe, T., T. C. Reynolds, G. Yu, and P. O. Brown. 1993. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:2099-2108.
25. Rott, O., J. Charreire, K. M. Godefroy, and E. Cash. 1995. B cell superstimulatory influenza virus activates peritoneal B cells. J. Immunol. 155:134-142.
26. Scherer, M. T., L. Ignatowicz, G. M. Winslow, J. W. Kappler, and P. Marrack. 1993. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu. Rev. Cell Biol. 9:101-128.
27. Testi, R., D. D'Ambrosio, R. De Maria, and A. Santoni. 1994. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol. Today 15:479-4183.
28. Thorley Lawson, D. A., L. M. Nadler, A. K. Bhan, and R. T. Schooley. 1985. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. J. Immunol. 134:3007-3012.
29. Varmus, H. E., and R. Swanstrom. 1984. RNA tumor viruses, p. 369-512. In R. Weiss, N. Teich, H. E. Varmus, and J. Coffin (ed.), RNA tumor viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
30. Weiss, R., N. Teich, H. Varmus, and J. Coffin. 1985. RNA tumor viruses, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
31. Woodland, D., and M. A. Blackman. 1993. How do T-cell receptors, MHC molecules and superantigens get together? Immunol. Today 14:208-212.
32. Yokoyama, W., F. Kining, P. J. Kehn, G. M. B. Pereira, G. Stingl, J. E. Coligan, and E. M. Shevach. 1988. Characterization of a surface-expressed disulfide-linked dimer involved in murine T cell activation. J. Immunol. 141:369-376.